Weight-dependent differential contribution of insulin secretion and clearance to hyperinsulinemia of obesity

Regulatory Peptides

Volumn 152, Issue 1-3, 2009, Pages 1-7

  Erdmann, Johannes ^a,b   Mayr, Martina ^b   Oppel, Ulrich ^c   Sypchenko, Oleg ^c   Wagenpfeil, Stefan ^b   Schusdziarra, Volker ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Insulin secretion; Insulin resistance; Obesity

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN;

ADULT; ARTICLE; BODY MASS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN CLEARANCE; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; C-PEPTIDE; FEMALE; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; MALE; OBESITY;

EID: 57249104708     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2008.10.008     Document Type: Article

References (35)

1. Reaven G.M. Pathophysiology of insulin resistance in human disease. Physiol Rev 75 (1995) 473-486
2. Polonsky K.S., Given B.D., Hirsch L., Shapiro E.T., Tillil H., Galloway J.A., Frank B.H., Karrison T., and Van Cauter E. Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest 81 (1988) 435-441
3. Reaven G.M., Chen Y.D., Hollenbeck C.B., Sheu W.H., Ostrega D., and Polonsky K.S. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab 76 (1993) 44-48
4. Erdmann J., Lippl F., Wagenpfeil S., and Schusdziarra V. Differential association of basal and postprandial plasma ghrelin with leptin, insulin, and type 2 diabetes. Diabetes 54 (2005) 1371-1378
5. Karam J.H., Grodsky G.M., and Forsham P.H. Excessive insulin response to glucose in obese subjects as measured by immunochemical assay. Diabetes 12 (1963) 197-204
6. Perley M., and Kipnis D.M. Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects. Diabetes 15 (1966) 867-874
7. Faber O.K., Christensen K., Kehlet H., Madsbad S., and Binder C. Decreased insulin removal contributes to hyperinsulinemia in obesity. J Clin Endocrinol Metab 53 (1981) 618-621
8. Bonora E., Zavaroni I., Bruschi F., Alpi O., Pezzarossa A., Guerra L., Dall'Aglio E., Coscelli C., and Butturini U. Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism?. J Clin Endocrinol Metab 59 (1984) 1121-1127
9. Muscelli E., Camastra S., Catalano C., Galvan A.Q., Ciociaro D., Baldi S., and Ferrannini E. Metabolic and cardiovascular assessment in moderate obesity: effect of weight loss. J Clin Endocrinol Metab 82 (1997) 2937-2943
10. Sims E.A., Danforth Jr. E., Horton E.S., Bray G.A., Glennon J.A., and Salans L.B. Endocrine and metabolic effects of experimental obesity in man. Recent Prog Horm Res 29 (1973) 457-496
11. Rabinowitz D., and Zierler K.L. Forearm metabolism in obesity and its response to intra-arterial insulin. Characterization of insulin resistance and evidence for adaptive hyperinsulinism. J Clin Invest 41 (1962) 2173-2181
12. Ferrannini E., Natali A., Bell P., Cavallo-Perin P., Lalic N., and Mingrone G. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest 100 (1997) 1166-1173
13. Jones C.N., Pei D., Staris P., Polonsky K.S., Chen Y.D., and Reaven G.M. Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals. J Clin Endocrinol Metab 82 (1997) 1834-1838
14. Walton C., Godsland I.F., Proudler A.J., Felton C.V., and Wynn V. Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men. J Clin Endocrinol Metab 75 (1992) 170-175
15. Meistas M.T., Margolis S., and Kowarski A.A. Hyperinsulinemia of obesity is due to decreased clearance of insulin. Am J Physiol 245 (1983) E155-E159
16. Zuniga-Guajardo S., Jimenez J., Angel A., and Zinman B. Effects of massive obesity on insulin sensitivity and insulin clearance and the metabolic response to insulin as assessed by the euglycemic clamp technique. Metabolism 35 (1986) 278-282
17. Jones C.N., Abbasi F., Carantoni M., Polonsky K.S., and Reaven G.M. Roles of insulin resistance and obesity in regulation of plasma insulin concentrations. Am J Physiol Endocrinol Metab 278 (2000) E501-E508
18. Rossell R., Gomis R., Casamitjana R., Segura R., Vilardell E., and Rivera F. Reduced hepatic insulin extraction in obesity: relationship with plasma insulin levels. J Clin Endocrinol Metab 56 (1983) 608-611
19. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech. Rep. Ser. 854 (1995) 368-369
20. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and ß-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
21. Eaton R.P., Allen R.C., Schade D.S., Erickson K.M., and Standefer J. Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behaviour. J Clin Endocrinol Metab 51 (1980) 520-528
22. Polonsky K.S., Given B.D., Pugh W., Licinio-Paixao J., Thompson J.E., Karrison T., and Rubenstein A.H. Calculation of the systemic delivery rate of insulin in normal man. J Clin Endocrinol Metab 63 (1986) 113-118
23. Licinio-Paixao J., Polonsky K.S., Given B.D., Pugh W., Ostrega D., Frank B., and Rubenstein A.H. Ingestion of a mixed meal does not affect the metabolic clearance rate of biosynthetic human C-peptide. J Clin Endocrinol Metab 63 (1986) 401-403
24. Van Cauter E., Metrez F., Sturis J., and Polonsky K.S. Estimation of insulin secretion rates from C-peptide levels - comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41 (1992) 368-377
25. Greenblatt D.J., and Kochweser J. Drug therapy: clinical pharmacokinetics. N Engl J Med 293 (1975) 702-705
26. Shuster L.T., Go V.L., Rizza R.A., O'Brien P.C., and Service F.J. Incretin effect due to increased secretion and decreased clearance of insulin in normal humans. Diabetes 37 (1988) 200-203
27. Ferrannini E., Camastra S., Gastaldelli A., Sironi A.M., Natali A., Muscelli E., Mingrone G., and Mari A. ß-cell function in obesity. Effects of weight loss. Diabetes 53 (2004) S26-S33
28. Ferrannini E., and Cobelli C. The kinetics of insulin in man. II. The role of the liver. Diabetes Metab Rev 3 (1987) 364-375
29. Tillil H., Shapiro E.T., Rubenstein A.H., Galloway J.A., and Polonsky K.S. Reduction of insulin clearance during hyperglycemic clamp. Dose-response study in normal humans. Diabetes 37 (1988) 1351-1357
30. Knutson V.P. Cellular trafficking and processing of the insulin receptor. FASEB J 5 (1991) 2130-2138
31. Meier J.J., Veldhuis J.D., and Butler P.C. Pulsatile insulin secretion dictates systemic delivery by regulating hepatic insulin extraction in humans. Diabetes 54 (2005) 1649-1656
32. Meier J.J., Holst J.J., Schmidt W.E., and Nauck M.A. Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans. Am J Physiol Endocrinol Metab 293 (2007) E849-E856
33. Boden G. Fatty acids and insulin resistance (review). Diabetes Care 19 (1996) 394-395
34. Balent B., Goswami G., Goofloe G., Rogatsky E., Rauta O., Nezami R., Mints L., Angeletti R.H., and Stein D.T. Acute elevation of NEFA causes hyperinsulinemia without effect on insulin secretion rate in healthy human subjects. Ann N Y Acad Sci 967 (2002) 535-543
35. Erdmann J., Kallabis B., Oppel U., Sypchenko O., Wagenpfeil S., and Schusdziarra V. Development of hyperinsulinemia and insulin resistance during the early stage of weight gain. Am J Physiol Endocrinol Metab 294 (2008) E568-E575